Valiant Laboratories (VALIANTLAB) Share Price near 52-week high as stock trades at Rs 130.35

Valiant Laboratories Share Price is Rs 130.35, up 1.68% from the previous session, and the stock is trading close to its 52-week high as of 16 October 2026 at 9:22 AM IST. The company’s market capitalisation stands at Rs 663.7 Cr, which places the latest move in a clear valuation and size context for Valiant Laboratories Ltd. (VALIANTLAB). The latest Univest figures confirm the price event, but they do not establish a company-specific catalyst for the move.

Valiant Laboratories Share Price today matters because the stock is holding near its yearly high while the broader market continues to track Stocks in News and 52 Week High Stocks. The current quote, the day’s range and the company’s financial ratios give readers a quick snapshot of Valiant Laboratories Share Price Today, while the latest Univest data keeps the focus on verifiable facts rather than assumptions. For readers following Valiant Laboratories Stock News, the key point is simple: the share is trading close to a one-year high, and that makes valuation, revenue context and sector comparison relevant.

Valiant Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 130.35
Previous Close	Rs 128.2
Today's Move	+Rs 2.15 (+1.68%)
Open	Rs 129.1
High	Rs 130.35
Low	Rs 127.4
Market Capitalisation	Rs 663.7 crore

Valiant Laboratories Ltd. (VALIANTLAB) traded at Rs 130.35 versus the previous close of Rs 128.2, a rise of 1.68%. The stock opened at Rs 129.1, reached a high of Rs 130.35 and touched a low of Rs 127.4.

Valiant Laboratories Share Price opened at Rs 129.10, moved between Rs 127.40 and Rs 130.35, and last traded at Rs 130.35. That compares with the previous close of Rs 128.20, which means the stock was up Rs 2.15 or 1.68% during the morning trade. The current quote is at the day’s high, and the stock is also close to its 52-week high event, which is why Valiant Laboratories Share Price Today is drawing attention in market screens.

For readers tracking Valiant Laboratories Share Price Update, the relevant takeaway is the price position relative to the recent range and the yearly high area. The latest Univest data confirms the event, but it does not identify a company-specific reason. For Valiant Laboratories Stock News Today, the move is best read as a price event first, with fundamentals and sector context providing the next layer of interpretation.

Valiant Laboratories Ltd. (VALIANTLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 663.7 crore
P/E Ratio	43.5x
P/B Ratio	2.1x
ROE	-0.93%
ROCE	-0.4%
EPS	Rs 2.95
Book Value Per Share	Rs 61.13
Dividend Yield	0%

Valiant Laboratories Ltd. (VALIANTLAB) fundamental metrics show P/E 43.5x, P/B 2.1x, ROE -0.93%, ROCE -0.4%. These figures provide context only and are not a buy or sell signal.

Valiant Laboratories Ltd. has a market capitalisation of Rs 663.7 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 43.5x, P/B at 2.1x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -0.93% and ROCE of -0.4%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.95, book value per share of Rs 61.13, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.24x, median ROE of 11.48%, median ROCE of 13.28%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	43.5x
Benchmark Median P/E	27.24x
Benchmark Average P/E	39.6x
Benchmark P/E Range	0x to 640x
Company P/B Ratio	2.1x
Benchmark Median P/B	2.82x
Company ROE	-0.93%
Benchmark Median ROE	11.48%
Company ROCE	-0.4%
Benchmark Median ROCE	13.28%
Company Market Capitalisation	Rs 663.7 crore
Benchmark Median Market Cap	Rs 821.66 crore

Valiant Laboratories Ltd. (VALIANTLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Valiant Laboratories Ltd. (VALIANTLAB) has a P/E ratio of 43.5x, which is above the benchmark median of 27.24x, a difference of +59.69%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Valiant Laboratories Ltd. (VALIANTLAB) has a ROE of -0.93%, which is below the benchmark median of 11.48%, a difference of -108.1%. Valiant Laboratories Ltd. (VALIANTLAB) has a ROCE of -0.4%, which is below the benchmark median of 13.28%, a difference of -103.01%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Wanbury Ltd.	WANBURY	669.44	11.67	4.45	67.87	30.31
INFLUX HEALTHTECH LIMITED	INFLUX	632.01	30.76	6.27	20.38	27.22
Amanta Healthcare Ltd.	AMANTA	736.59	50.19	3.3	9.4	11.23
Zim Laboratories Ltd.	ZIMLAB	783.95	203.18	2.58	2.14	5.47
Kilitch Drugs (India) Ltd.	KILITCH	806.56	27.59	2.95	12.26	14.5

Valiant Laboratories Ltd. (VALIANTLAB) has a P/E ratio of 43.5x compared with the displayed peer median of 30.76x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.93% compares with a peer median of 12.26% across the companies shown in the table. ROCE stood at -0.4% versus the displayed peer median of 14.5%, providing a capital-efficiency comparison. Valiant Laboratories Ltd. (VALIANTLAB) has a market capitalisation of Rs 663.7 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Valiant Laboratories

• Valiant Laboratories Share Price is Rs 130.35, which is near its 52-week high.
• Valiant Laboratories Share Price Today is up 1.68% from the previous close of Rs 128.20.
• The company’s market capitalisation is Rs 663.7 Cr, placing it below the industry median.
• P/E stands at 43.5, above the same-industry median of 27.24.
• ROE is -0.93 and ROCE is -0.4, which keeps Valiant Laboratories Fundamental Analysis in focus.

About Valiant Laboratories

Valiant Laboratories Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. For readers following Valiant Laboratories Share Price, the company profile matters because sector classification helps frame valuation and peer comparison. Valiant Laboratories Stock News and Valiant Laboratories Company News are therefore best read together with market cap, earnings metrics and the industry benchmark rather than in isolation.

Frequently Asked Questions

What is Valiant Laboratories Share Price today?

Ans. Valiant Laboratories Share Price is Rs 130.35, and it is up 1.68% from the previous close of Rs 128.20. The stock is also trading near its 52-week high.

Why is Valiant Laboratories Share Price in focus?

Ans. Valiant Laboratories Share Price is in focus because it is trading close to a 52-week high. The latest Univest figures confirm the price event, while no company-specific catalyst is identified in the available market data.

What is the market capitalisation of Valiant Laboratories?

Ans. Valiant Laboratories has a market capitalisation of Rs 663.7 Cr. That places Valiant Laboratories Share Price in a smaller benchmark context than the same-industry median of Rs 821.66 Cr.

How does Valiant Laboratories compare on valuation?

Ans. Valiant Laboratories Share Price carries a P/E of 43.5 and a P/B of 2.1. Its P/E is above the same-industry median of 27.24, while its P/B is below the median of 2.82.

What do the latest return ratios show for Valiant Laboratories?

Ans. Valiant Laboratories reports ROE of -0.93% and ROCE of -0.4%. Those figures are below the same-industry medians, so Valiant Laboratories Fundamental Analysis remains important for readers tracking the share.

What is the latest revenue figure for Valiant Laboratories?

Ans. The latest quarterly revenue shown for Valiant Laboratories is Rs 115.29 Cr for Jun 2026. That revenue figure gives context to Valiant Laboratories Share Price alongside EPS of 2.95 and book value of Rs 61.13.

How does Valiant Laboratories compare with peers?

Ans. Compared with peers such as Wanbury, INFLUX HEALTHTECH LIMITED and Amanta Healthcare, Valiant Laboratories Share Price sits above some valuation multiples and below others, while its ROE and ROCE are weaker than the listed peer figures.

Where can I track Valiant Laboratories Share Price live?

Ans. Readers can track Valiant Laboratories Share Price on Univest for live price updates, 52-week levels, valuation ratios, quarterly revenue and peer comparison. That makes it easier to follow Valiant Laboratories Stock News in one place.

Track Valiant Laboratories Share Price on Univest

Use Valiant Laboratories Ltd. (VALIANTLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Valiant Laboratories Share Price on Univest for live price updates, 52-week levels, valuation ratios, quarterly revenue, peer comparison and market insights. Univest also helps readers follow Valiant Laboratories Share Price Today alongside Valiant Laboratories Latest News and Valiant Laboratories Stock Analysis in one place.

Valiant Laboratories Share Price remains a market-watch name because the stock is near a 52-week high, while its fundamentals and sector benchmark create a mixed but measurable backdrop for Valiant Laboratories Stock Performance and Valiant Laboratories Share Price Update.